Critical Survey: Integer Holdings (ITGR) vs. Medtronic plc. (MDT)
Integer Holdings (NASDAQ: ITGR) and Medtronic plc. (NYSE:MDT) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability.
This table compares Integer Holdings and Medtronic plc.’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation & Earnings
This table compares Integer Holdings and Medtronic plc.’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Integer Holdings||$1.41 billion||1.01||$275.57 million||N/A||N/A|
|Medtronic plc.||$29.93 billion||3.63||$9.23 billion||$2.97||26.89|
Medtronic plc. has higher revenue and earnings than Integer Holdings.
Medtronic plc. pays an annual dividend of $1.84 per share and has a dividend yield of 2.3%. Integer Holdings does not pay a dividend. Medtronic plc. pays out 62.0% of its earnings in the form of a dividend. Medtronic plc. has raised its dividend for 39 consecutive years.
Risk & Volatility
Integer Holdings has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, Medtronic plc. has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.
This is a breakdown of current ratings for Integer Holdings and Medtronic plc., as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Integer Holdings presently has a consensus price target of $35.00, indicating a potential downside of 22.74%. Medtronic plc. has a consensus price target of $88.82, indicating a potential upside of 11.22%. Given Medtronic plc.’s stronger consensus rating and higher probable upside, analysts clearly believe Medtronic plc. is more favorable than Integer Holdings.
Insider and Institutional Ownership
80.5% of Medtronic plc. shares are owned by institutional investors. 0.3% of Medtronic plc. shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Medtronic plc. beats Integer Holdings on 13 of the 16 factors compared between the two stocks.
Integer Holdings Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Medtronic plc. Company Profile
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company’s subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
Receive News & Ratings for Integer Holdings Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer Holdings Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.